Alzheimer’s disease remains one of the most challenging neurodegenerative disorders to treat, with its progressive cog...
LIFE SCIENCES: presentation all the Projects Approved for Funding Under the Booster for Life Science FVG Notice | Proposal for Further Insights
On December 10th, the event dedicated to the presentation of the projects selected through the first call of the notice ...
Amyloid Is Everywhere, but New Treatments Could Stop the Toxic Build Up
Amyloid deposits are not only present in the brains of cognitively impaired individuals but also accumulate throughout t...
Innovating Protease Inhibition: Advancing Targeted Therapies for Disease Treatment
Protease inhibition faces challenges due to specificity and safety concerns. Innovative approaches, including non-natura...
Pandemics: Siena Biotech Hub to Coordinate European Network. Projects for 2025
The year 2025 will mark the definitive relaunch of the Siena Biotech Hub Foundation. The Italian government aims to posi...
Oncology: GSK Acquires U.S. Biotech IDRx
The British pharmaceutical giant GSK has announced the acquisition of the Boston-based biopharmaceutical company IDRx fo...